Harrow, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Harrow, Inc. now
Current reporting with the operating signal separated from the noise.
Is Harrow, Inc. (HROW) A Good Stock To Buy Now?
Investors are testing whether Harrow, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Harrow, Inc.: Harrow Health, Inc. Reaffirms 2025 Full-Year Revenue Guidance of $270-$280 Million, Marking Another Year of Strong Growth
Investors are testing whether Harrow, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Harrow, Inc. (HROW) Q3 2024 Earnings Call Transcript
Investors are testing whether Harrow, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Latest HROW filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Harrow, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →